
Laurus Labs Limited — Investor Relations & Filings
Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Please see annexed enclosure. | 2026-06-08 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-06-08 | English | |
| Please see annexed enclosure. | 2026-06-08 | English | |
| General Updates | 2026-06-08 | English | |
| Updates | 2026-06-08 | English | |
| Please see annexed enclosure. | 2026-06-08 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47998699 | Please see annexed enclosure. | 2026-06-08 | English | ||
| 47998603 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-06-08 | English | ||
| 47998704 | Please see annexed enclosure. | 2026-06-08 | English | ||
| 47998632 | General Updates | 2026-06-08 | English | ||
| 47996544 | Updates | 2026-06-08 | English | ||
| 47995938 | Please see annexed enclosure. | 2026-06-08 | English | ||
| 47995954 | Please see annexed enclosure. | 2026-06-08 | English | ||
| 47995702 | Shareholders meeting | 2026-06-08 | English | ||
| 47995518 | Please see annexed enclosure. | 2026-06-08 | English | ||
| 47978059 | Please see annexed enclosure. | 2026-06-05 | English | ||
| 47977875 | Copy of Newspaper Publication | 2026-06-05 | English | ||
| 47975403 | Disclosure under SEBI Takeover Regulations | 2026-06-05 | English | ||
| 47966288 | Please see annexed enclosure. | 2026-06-04 | English | ||
| 47965940 | Updates | 2026-06-04 | English | ||
| 47881815 | Please see annexed enclosure. | 2026-05-29 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
LITTLE GREEN PHARMA LTD
Vertically integrated producer of pharmaceutical-grade medi…
|
LGP | AU | Manufacturing |
|
Liven Pharma Limited
Manufactures and markets a range of pharmaceutical and alli…
|
LIVEN | PK | Manufacturing |
|
Liven Pharma Limited(Right)
Manufactures and sells a range of pharmaceutical and allied…
|
LIVENR | PK | Manufacturing |
|
Livzon Pharmaceutical Group Inc.
Integrates R&D, production, and sales of finished pharmaceu…
|
1513 | CN | Manufacturing |
|
Lobe Sciences Ltd.
Clinical-stage biopharma developing therapies for rare and …
|
LOBE | CA | Manufacturing |
|
Longeveron Inc.
Clinical-stage biotech developing cell therapies for aging …
|
LGVN | US | Manufacturing |
|
Lonza Group AG
A global CDMO for the pharmaceutical, biotech, and nutritio…
|
LONN | CH | Manufacturing |
|
Lophos Holdings Inc.
Bioscience company researching, cultivating, and developing…
|
MESC | CA | Manufacturing |
|
Lotus Pharm
Global specialty firm focused on high-barrier generic and s…
|
1795 | TW | Manufacturing |
|
LSL Pharma Group Inc.
Integrated CDMO focused on developing and manufacturing spe…
|
LSL | CA | Manufacturing |
Laurus Labs Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62639/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62639 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62639 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62639 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62639}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Laurus Labs Limited (id: 62639)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.